Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > TLD-1433 kills various viruses within seconds
View:
Post by ScienceFirst on Jul 11, 2022 10:24pm

TLD-1433 kills various viruses within seconds

A refresher ... on how potent and intended for which usage and also what subset of patients:


Theralase compound can kill influenza virus, Zika virus and human coronaviruses within seconds.

Thus, 
the compound may represent a very rapid and very safe alternative to standard methods that are used to prepare inactivated virus vaccines, and may also be useful as a therapeutic for individuals who cannot receive normal vaccines.
Comment by Lesalpes29 on Jul 12, 2022 8:01am
April 9th of last year we had the first TLT NR about a possible vaccine develop by TLT and their tech. 15 months later we are still waiting to see if it's working on animals? If positive results it could take an other 1 year +? BTD well before hopefully!
Comment by ScienceFirst on Jul 12, 2022 8:57am
Lesalpes29 ...  What's interesting with the COVID-19 indication is that if the last preclinical milestone (the current animal testing) is successful, then NML will recommand us for government funding (securing doses by the government, etc ...), just like it happened for other COVID-19 innovations (MEDICAGO, etc ...). And a recommandation from NML would instantly bring a credibility ...more  
Comment by Rumpl3StiltSkin on Jul 12, 2022 9:19am
Yes, this would be huge for TLT. Should see a corresponding spike in SP of a cpl $$s at least.
Comment by StevenBirch on Jul 12, 2022 9:27am
And we sort of know the timeline for NMIBC data to come in, not too far away, but this could come at any time. I'm back to eagerly looking for a news release every morning if not the daily trading that follows.
Comment by Oilminerdeluxe on Jul 12, 2022 9:45am
Man, I yearn to  know about how the next 270 and 360 day  data looks like. A sharp increase in CR and everything could change just like that. 
Comment by 99942Apophis on Jul 12, 2022 11:14am
Oilminerdeluxe wrote Man, I yearn to  know about how the next 270 and 360 day  data looks like. A sharp increase in CR and everything could change just like that.  Perhaps I can add to your excitement Oilminerdeluxe!  Looking at my patient chart it appears patients 21 to 24 will be hitting their 270 day at the end of June/2022 interestingly patient 25 might hit 270 somewhere ...more  
Comment by Oilminerdeluxe on Jul 12, 2022 11:40am
Thanks Apophis. Sure did :-)
Comment by enriquesuave on Jul 12, 2022 11:55am
From April 5th PH2 trial update till now, 4 extra patients have reached 270 days   5 extra patients will have reached 180 days .  2 more patients hit 360 days .  Early August probably a few more May hit those timelines?  
Comment by Rumpl3StiltSkin on Jul 12, 2022 11:02am
It immediatley solves any perceived Money $$ problem doesn't it? Also gives them an immediate revenue stream that is probably larger, in the short term, than NMIBC... Like having a major Cancer indication under their belt... Instantly. :-)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250